Kyle J Moody
Examiner (ID: 8172, Phone: (571)272-5242 , Office: P/2838 )
Most Active Art Unit | 2838 |
Art Unit(s) | 2838 |
Total Applications | 778 |
Issued Applications | 667 |
Pending Applications | 60 |
Abandoned Applications | 51 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18981357
[patent_doc_number] => 11906521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen
[patent_app_type] => utility
[patent_app_number] => 17/482918
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 7396
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482918 | Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen | Sep 22, 2021 | Issued |
Array
(
[id] => 18931107
[patent_doc_number] => 11883501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Selective CXCR4 binding peptide conjugate and methods for making and using the same
[patent_app_type] => utility
[patent_app_number] => 17/479920
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13621
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479920 | Selective CXCR4 binding peptide conjugate and methods for making and using the same | Sep 19, 2021 | Issued |
Array
(
[id] => 19425073
[patent_doc_number] => 12084476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/476041
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18904
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/476041 | Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors | Sep 14, 2021 | Issued |
Array
(
[id] => 19026333
[patent_doc_number] => 11925673
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Treatment of age-related macular degeneration
[patent_app_type] => utility
[patent_app_number] => 17/471446
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 9059
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471446 | Treatment of age-related macular degeneration | Sep 9, 2021 | Issued |
Array
(
[id] => 17458784
[patent_doc_number] => 20220072088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => REDUCING CLOSTRIDIUM PERFRINGENS VIRULENCE USING INHIBITORS OF AGR-LIKE QUORUM SENSING
[patent_app_type] => utility
[patent_app_number] => 17/470775
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470775 | REDUCING CLOSTRIDIUM PERFRINGENS VIRULENCE USING INHIBITORS OF AGR-LIKE QUORUM SENSING | Sep 8, 2021 | Pending |
Array
(
[id] => 19505010
[patent_doc_number] => 12116421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Peptide-based Dopa containing adhesive gels
[patent_app_type] => utility
[patent_app_number] => 18/021645
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 45
[patent_no_of_words] => 14086
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021645
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021645 | Peptide-based Dopa containing adhesive gels | Sep 1, 2021 | Issued |
Array
(
[id] => 17541024
[patent_doc_number] => 11306135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Anti-VEGF protein compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/460578
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67810
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460578 | Anti-VEGF protein compositions and methods for producing the same | Aug 29, 2021 | Issued |
Array
(
[id] => 19354103
[patent_doc_number] => 12054532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Anti-VEGF protein compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/458519
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67460
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458519 | Anti-VEGF protein compositions and methods for producing the same | Aug 25, 2021 | Issued |
Array
(
[id] => 17428366
[patent_doc_number] => 20220056074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/401434
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401434 | PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES | Aug 12, 2021 | Pending |
Array
(
[id] => 17760020
[patent_doc_number] => 20220233632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => MODULATORS OF COMPLEMENT ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/400267
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400267 | Modulators of complement activity | Aug 11, 2021 | Issued |
Array
(
[id] => 17214492
[patent_doc_number] => 20210347829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ARC-BASED CAPSIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/382092
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382092 | Endogenous Gag-based capsids and uses thereof | Jul 20, 2021 | Issued |
Array
(
[id] => 17443704
[patent_doc_number] => 20220064209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS OF PURIFYING POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/369765
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369765 | METHODS OF PURIFYING POLYPEPTIDES | Jul 6, 2021 | Pending |
Array
(
[id] => 18177909
[patent_doc_number] => 20230038638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPLEMENT FACTOR I-RELATED COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/347442
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347442 | Complement factor I-related compositions and methods | Jun 13, 2021 | Issued |
Array
(
[id] => 17110193
[patent_doc_number] => 20210290790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR PRODUCING PROTEIN COMPOSITION, AND PROTEIN COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/336672
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336672
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336672 | Method for producing protein composition, and protein composition | Jun 1, 2021 | Issued |
Array
(
[id] => 17776566
[patent_doc_number] => 20220242915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => SODIUM CHANNEL PROTEIN NAV1.4-TARGETING POLYPEPTIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/329194
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329194 | Sodium channel protein Nav1.4-targeting polypeptide and use thereof | May 24, 2021 | Issued |
Array
(
[id] => 17428372
[patent_doc_number] => 20220056080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Muramyl Peptide Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/328078
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328078 | Muramyl Peptide Derivatives | May 23, 2021 | Pending |
Array
(
[id] => 17082051
[patent_doc_number] => 20210277057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/328045
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328045 | ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS | May 23, 2021 | Pending |
Array
(
[id] => 17185231
[patent_doc_number] => 20210332116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => SINGLE DOMAIN BINDING MOLECULE
[patent_app_type] => utility
[patent_app_number] => 17/322139
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322139 | Single domain binding molecule | May 16, 2021 | Issued |
Array
(
[id] => 17299479
[patent_doc_number] => 20210395318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MULTISPECIFIC PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/302898
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302898 | MULTISPECIFIC PROTEINS | May 13, 2021 | Pending |
Array
(
[id] => 17228912
[patent_doc_number] => 20210355468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 17/320386
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320386 | COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA | May 13, 2021 | Abandoned |